Browse Category

NASDAQ:QCLS News 4 December 2025 - 5 December 2025

Q/C Technologies (QCLS) Stock: Shkreli-Fueled Quantum-Class Rally, Latest News and Forecasts as of December 5, 2025

Q/C Technologies (QCLS) Stock: Shkreli-Fueled Quantum-Class Rally, Latest News and Forecasts as of December 5, 2025

Q/C Technologies, Inc. (NASDAQ: QCLS) has suddenly gone from obscure microcap to social‑media star. Over just two trading sessions, the stock has effectively doubled after former pharma executive Martin Shkreli disclosed a position, floated a near‑term $100 price target, and hinted at wanting to run the company if regulators ever let him back into a C‑suite. Benzinga Underneath the drama…
Q/C Technologies (QCLS) Stock Skyrockets on Martin Shkreli’s $100 ‘Quantum-Class’ Call – What’s Really Behind the Rally on December 4, 2025

Q/C Technologies (QCLS) Stock Skyrockets on Martin Shkreli’s $100 ‘Quantum-Class’ Call – What’s Really Behind the Rally on December 4, 2025

Microcap quantum‑class computing and blockchain play Q/C Technologies has doubled in two sessions after Martin Shkreli unveiled a bold $100 price target. Here’s what’s driving QCLS – and the risks behind the hype. QCLS stock today: a tiny name with huge moves By early afternoon on December 4, 2025, shares of Q/C Technologies, Inc. (NASDAQ: QCLS) were trading around $6.7–$6.8,…

Stock Market Today

  • Veradermics CEO Sees 122% Surge in IPO as Investors Back Oral Rogaine Biotech
    February 5, 2026, 2:43 PM EST. Veradermics, a biotech firm developing an oral form of Rogaine, saw its initial public offering (IPO) jump 122%, reflecting investor confidence in new treatments for hair loss. The company aims to tap into the growing market driven by aesthetic concerns. By betting on easy-to-use therapies, investors signal belief in demand for hair restoration beyond topical solutions. The strong IPO debut underscores appetite for innovation within the biotech sector focusing on consumer-focused health products.
Go toTop